Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 82Thoracic 5Head & Neck 4Gynecologic 2CNS 2Sarcoma 1Genitourinary 1

Conditions

Uterine Cervical Neoplasms 9Ovarian Neoplasms 9Colorectal Neoplasms 7Endometrial Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Neoplasm Metastasis 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Rectal Neoplasms 2Peritoneal Neoplasms 2Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Sarcoma 1Recurrence 1Prostatic Neoplasms 1Melanoma 1Kidney Neoplasms 1Fallopian Tube Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Biliary Tract Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Early Intervention, Educational 6Oxaliplatin 5Methods 4Cisplatin 4pembrolizumab 3Trastuzumab 3Surveys and Questionnaires 3Specimen Handling 3Leucovorin 3Fluorouracil 3Carboplatin 3X-Rays 2Radiotherapy 2Observation 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Irinotecan 2Interleukin-12 Subunit p35 2Gemcitabine 2Cyclophosphamide 2Counseling 2Cetuximab 2Capecitabine 2Biopsy 2veliparib 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sodium thiosulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Rectal Neoplasms × Cetuximab × Gynecologic × Clear all
NCT06607185 2026-05-26

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Eli Lilly and Company

Phase 1 Active not recruiting
750 enrolled
GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT00766142 2025-08-29

COCHISE

Institut Bergonié

Phase 2 Terminated
18 enrolled 9 charts
GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡